Small Bowel Disease
23
3
3
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
1 terminated out of 23 trials
90.9%
+4.4% vs benchmark
9%
2 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (23)
Histomolecular Profiling in Small-Bowel Diseases
Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis
Anonymous Data Sharing for Small Bowel
Utility of Motorized Spiral Enteroscopy for Suspected Small Bowel Pathology
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
A Clinical Study With the Medical Device PowerSpiral for Deep Enteroscopy
Performance Evaluation of the NaviCam SB Capsule Endoscope System for the Diagnosis of Small Bowel Diseases
PowerSpiral Enteroscopy Performance and Safety
Novel Motorized Spiral Enteroscopy Vs Single Balloon Enteroscopy In Patients With Small Bowel Disorders- A RCT
Mini-sized MCE for Detection of Small Bowel in Children Under the Age of 10 Years
The PowerSpiral Antegrade Investigational Device Exemption (IDE) Study
Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis
Learning Small Bowel Capsule Endoscopy
Small Bowel Evaluation Using Novel Motorized Spiral Enteroscopy
Small Bowel Capsule Endoscopy: Experience From a Single Large Tertiary Care Centre
Study of Oro-cecal Transit Time in Healthy Subjects Using Scintigraphy and Lactulose Hydrogen Breath Test.
Evaluation of PillCam® Express Capsule Endoscopy Delivery System
Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users
Magnetic Steering Improves Small Bowel Capsule Endoscopy Completion Rate
Impact of Diet on Capsule Endoscopy